Search the Newsreel

Brokers Issue Forecasts for Datavault AI FY2026 Earnings

Avista Announces New Vice President Appointments

Avista (NYSE: AVA) announced leadership changes, effective October 1, 2026, promoting Alicia Gibbs to Vice President, Growth, Innovation and Strategy, and Patrick Ehrbar to Vice President, Regulatory Affairs. These appointments are part of a planned succession strategy to enhance strategic execution, support growth, and …

Theravance Biopharma, Inc. 2026: Revenue $20.73M, EPS ($0.11) — 10-Q Summary

Theravance Biopharma, Inc. (TBPH) reported its 2026 quarterly results, showing a significant decrease in revenue and a net loss compared to the prior year. Revenue dropped by 20.9% to $20.73M, resulting in a diluted EPS of ($0.11) versus $1.08 previously, largely due to the …

Theravance Biopharma (TBPH) agrees $17 cash sale to Zymeworks plus CVRs

AvalonBay Communities, Inc. $AVB Shares Sold by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab significantly reduced its stake in AvalonBay Communities (NYSE: AVB) by 84% in the second quarter, selling 21,622 shares and retaining 4,120 shares valued at approximately $777,000. Despite the sell-off, institutional investors still collectively own 92.61% of AVB. Wall Street analysts generally hold …

Do Avalo Therapeutics’ (AVTX) Widening Losses But Better EPS Reveal a Turning Point in Strategy?

Nasdaq puts $675 million Avalanche Treasury on the clock over two listing failures

Nasdaq has given Avalanche Treasury Corporation (AVAT) until February 2, 2027, to resolve two listing deficiencies: its share price falling below $1 and its market value of listed securities dropping below $35 million. AVAT's stock must more than triple to meet the bid-price test, …

Renaissance Technologies LLC Acquires New Holdings in Theravance Biopharma, Inc. $TBPH

Renaissance Technologies LLC has acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH), purchasing 127,916 shares valued at approximately $2.076 million. This makes Renaissance Technologies LLC one of many institutional investors with holdings in TBPH, as they collectively own 99.10% of the company's stock. …

Press Release: Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. (TBPH) reported its second quarter 2026 financial results, highlighting a significant 15% increase in total revenue year-over-year, reaching $40 million. The company's net loss decreased by 10% to $18 million, or $0.30 per share, demonstrating improved financial performance. Key updates included …

Avista names two new vice presidents ahead of senior executive's retirement

Avista Corp. (NYSE: AVA) has appointed Alicia Gibbs as Vice President, Growth, Innovation and Strategy, and Patrick Ehrbar as Vice President, Regulatory Affairs. These appointments are part of a succession plan as Senior Vice President Jason Thackston is set to retire at the end …

Carnavale Resources (ASX:CAV) Rises With Kookynie Resource Growth In View

Savara (SVRA) Earnings Date and Reports 2026

Equities Analysts Issue Forecasts for AVTX Q3 Earnings

Cava Stock Earnings Expectations: Get Ready For a Big Move

Cava Group Inc (CAVA) is expected to announce its second-quarter earnings today, August 11, with analysts anticipating $0.18 per share and $353.31 billion in revenue. The stock has a history of significant post-earnings movement, with options traders bracing for a 17.1% swing, and it …

Earnings Flash (CAVA) CAVA Group, Inc. Reports Q2 Revenue $365.4M, vs. FactSet Est of $360.1M

CAVA Group, Inc. (CAVA) reported Q2 revenue of $365.4 million, surpassing FactSet's estimate of $360.1 million. This financial beat comes despite broader economic worries and previous outbreaks affecting the restaurant industry, demonstrating the company's strong performance. The news has led to a pre-bell jump …

Avista (AVA) Q2 2026 Earnings Call Transcript

Avista's Q2 2026 earnings call focused primarily on the devastating wildfires near Spokane, Washington, which caused significant damage to their electric and natural gas infrastructure. CEO Heather Rosentrater discussed the company's response, efforts to restore service, and the effectiveness of their wildfire mitigation strategies. …

Avista Plans Leadership Shift as Executive Prepares to Retire

Avista (NYSE: AVA) announced leadership changes effective October 1, 2026, as part of a planned succession strategy. Alicia Gibbs has been appointed Vice President, Growth, Innovation and Strategy, and Patrick Ehrbar has been appointed Vice President, Regulatory Affairs. These changes precede the planned retirement …

AvalonBay Communities (AVB) Faces A Valuation Test, Is An 9% Discount Enough?

AvalonBay Communities (AVB) has experienced recent stock price declines but is considered 8.7% undervalued with a fair value of $201.44 per share, according to Simply Wall St. The valuation is supported by expected long-term undersupply of housing and strong demand in its key markets, …

Earnings live updates: Nebius stock soars as AI cloud revenue jumps 514%, Cava gains on earnings beat

The second quarter earnings season is beginning to wind down, with nearly 90% of S&P 500 (^GSPC) companies having already reported. The takeaway from the quarter so far has been unbridled strength. According to FactSet data, second quarter earnings for S&P 500 companies are …

Cava Group's Second Quarter Earnings Outlook

Analysts predict Cava Group's revenue to grow by 28.3% to $360.1 million in Q2, with GAAP earnings per share increasing from $0.16 to $0.18, showcasing its growth in the fast-casual sector. Despite this, Cava's stock has declined from April highs due to industry pressures …

CAVA Group's Next Earnings Report on Aug. 11 Could Send the Stock Soaring. Here's Why.

Key Points The Mediterranean fast-casual chain has delivered impressive results since it went public in 2023. Young consumers seem to be coming back to fast-casual dining in what's become known as the "little treat economy." Cava is historically cheap at a price-to-sales ratio under …

Why Savaria Corporation stock is sliding today

Datavault AI Inc. Class Action Lawsuit Alert: Johnson Fistel Notifies Investors of October 5, 2026 Lead Plaintiff Deadline

Johnson Fistel, PLLP has announced a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) on behalf of investors who purchased securities between September 4, 2024, and October 30, 2025. The lawsuit alleges that Datavault AI made false and misleading statements regarding its business …

Why Avant Brands Inc stock is plummeting today

Theravance Biopharma earnings missed by $0.17, revenue fell short of estimates

Theravance Biopharma (NASDAQ:TBPH) Announces Quarterly Earnings Results, Meets Expectations

Theravance Biopharma (NASDAQ:TBPH) reported quarterly earnings per share of $0.07, matching analysts' consensus estimates. The company showed a strong return on equity of 18.84% and a net margin of 104.34%. Analysts currently maintain a "Hold" rating on the stock with a consensus price target …

Cavalier Resources (ASX:CVR) Rises As Crawford Gold Development Advances

Theravance Biopharma Q2 net loss turns to USD 5.9 million; revenue rises 11% to USD 20.7 million YoY

Theravance Biopharma reported a Q2 GAAP net loss of USD 5.9 million, a swing from a profit in the prior year, despite an 11% increase in revenue to USD 20.7 million, primarily from the Viatris collaboration. The company also saw reduced R&D and SG&A …

Wall Street Analysts See Cava (CAVA) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …

Is Theravance Biopharma Inc (TBPH) Undervalued After Q2 Earnings

Theravance Biopharma Inc (TBPH) released its Q2 2026 earnings, reporting an 11% increase in YUPELRI collaboration revenue to $20.7 million and a 35% reduction in operating expenses. Despite these gains and a solid cash balance, the company faces challenges, including a failed Phase 3 …

Earnings Flash (TBPH) Theravance Biopharma, Inc. Reports Q2 Revenue $20.7M, vs. FactSet Est of $22.5M

Theravance Biopharma, Inc. (TBPH) announced its Q2 revenue of $20.7 million, falling short of FactSet's estimate of $22.5 million. The company's stock was trading at 16.90 USD, reflecting a slight dip in performance. Theravance Biopharma specializes in developing and commercializing medicines for respiratory and …

Earnings Flash (TBPH) Theravance Biopharma Posts Q2 Net Loss $0.11 a Share, vs. FactSet Est of $0.07 EPS

Navan Upgrades Singapore Airlines NDC to Direct Connection

Integration brings exclusive fares and enhanced servicing for travelers PALO ALTO, Calif., August 10, 2026--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has upgraded its Singapore Airlines NDC access to a direct connection using the carrier's …

Earnings To Watch: Cava Group Inc (CAVA) Q2 2026 -- GF Value Sees 76% Upside

Cava Group Inc (CAVA) is scheduled to release its Q2 2026 earnings on August 11, 2026, with revenue estimates at $361.78 million and earnings at $0.14 per share. Analysts project an average target price of $92.32 for CAVA, suggesting a 47.9% upside, while GuruFocus …

Form 8K Theravance Biopharma Inc For: 10 August By Investing.com

This article announces that Theravance Biopharma Inc. filed a Form 8K on August 10, 2026. The filing is a standard SEC disclosure for significant corporate events. The brief note from Investing.com provides no further details about the content of the 8K.

Theravance's Once-Daily COPD Treatment Posts $70.7M Sales